An estimate of the annual direct cost of treating cutaneous melanoma. (Q50630949)

16 March 2018

title

An estimate of the annual direct cost of treating cutaneous melanoma. (English)

1 reference

16 March 2018

author name string

Tsao H

series ordinal

1

1 reference

16 March 2018

Rogers GS

series ordinal

2

1 reference

16 March 2018

Sober AJ

series ordinal

3

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

16 March 2018

Journal of the American Academy of Dermatology

published in

1 reference

16 March 2018

volume

38

1 reference

16 March 2018

issue

5 Pt 1

1 reference

16 March 2018

page(s)

669-680

1 reference

16 March 2018

Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis, and treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

1 reference

7 January 2021

Cost-effectiveness model for colon cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Cost-effectiveness of mammographic screening in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Estimates of costs and effects of screening for colorectal cancer in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Model predicting survival in stage I melanoma based on tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Screening for cutaneous melanoma by skin self-examination

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

The Role of Selective Lymphadenectomy in the Management of Patients with Malignant Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Minimal-access surgery for staging of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Palliative care of patients with terminal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

A comparative cost analysis of terminal cancer care in home hospice patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Comparison of home and hospital care of advanced cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Finally, a successful adjuvant therapy for high-risk melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

The economics of lung cancer management in Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Melanoma: prevention and early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Screening for melanoma by primary health care physicians: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Audit of public education campaign to encourage earlier detection of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

Adjuvant therapy for cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970195-1

7 January 2021

10.1016/S0190-9622(98)70195-1

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018